Latest Breaking News On - Subcutaneous epcoritamab with rituximab - Page 1 : comparemela.com

EPCORE FL-1: Phase 3 Trial of Subcutaneous Epcoritamab With Rituximab and Lenalidomide (R2) vs R2 Alone in Patients With Relapsed or Refractory Follicular Lymphoma

Lorenzo Falchi, MD, discusses the ongoing EPCORE FL-1 phase 3 trial investigating epcoritamab-rituximab-lenalidomide vs rituximab-lenalidomide in patients with relapsed or refractory follicular lymphoma.

United statesSan diegoLorenzo falchiDrug administrationEastern cooperative oncology groupSubcutaneous epcoritamab with rituximabPatients with relapsedRefractory follicularPartnership withNorth americaSouth americaSubcutaneous epcoritamabEpcore fl 1Follicular lymphomaRelapsed refractory follicular lymphomaEpcore fl 1 trial

Genmab Announces Multiple Abstracts to be Presented at the 65th Annual Meeting and Exposition of the American Society of Hematology (ASH)

Genmab Announces Multiple Abstracts to be Presented at the 65th Annual Meeting and Exposition of the American Society of Hematology (ASH)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesNew jerseyUnited kingdomSan diegoKalvebod bryggeDavid freundelHematol hemoterAndrew carlsenJudith klimovskyOutcomes researchAbbvie biotechnology ltdCompany announcementNational comprehensive cancer networkData from the observational national lymphocare studyDiscovery researchAmerican society of hematology

Genmab Announces Multiple Abstracts to be Presented at the 65th Annual Meeting and Exposition of the

Eighteen total abstracts accepted for presentation and publication, including results from four clinical trials evaluating epcoritamab in multiple treatment settings and patient populationsOral presentations highlighting new findings from a clinical trial of epcoritamab in patients with relapsed/refractory (R/R) dif.

San diegoUnited statesNew jerseyUnited kingdomHematol hemoterDavid freundelAndrew carlsenJudith klimovskyExchange commissionLymphoma research foundationCompany announcementOutcomes researchNational comprehensive cancer networkAbbvie biotechnology ltdAmerican society of hematologyDiscovery research